Meperidine / Promethazine

15 January 2009

Products Affected - Description

Meperidine / promethazine 50 mg / 25 mg tablets, Actavis
Meperidine / promethazine 50 mg / 25 mg tablets, Ethex

Meprozine 50 mg / 25 mg tablets, Qualitest

Mepergan (meperidine 25 mg/mL and promethazine 25 mg/mL) injection, Baxter

Reason for the Shortage

• Oral meperidine / promethazine products have been discontinued. The manufacturers would not provide a reason for the discontinuations; however these products are not FDA-approved.
• Mepergan injection has been discontinued.

Estimated Resupply Dates

All combination meperidine plus promethazine products are discontinued.

Related Shortages

• Alfentanil Injection— Resolved
• Butorphanol Injection— Resolved
• Choline Magnesium Trisalicylate
• Codeine Phosphate Oral Solution— No Longer Available
• Diazepam Injection— Resolved
• Fentanyl Transdermal System Patch— Resolved
• Hydrocodone Tablets
• Hydromorphone Hydrochloride Injection
• Indomethacin Capsules— Resolved
• Meperidine— Resolved
• Methadone Hydrochloride Injection— Resolved
• Methadone Hydrochloride Tablets— Resolved
• Methadone Injection— Resolved
• Methadone Oral Tablets and Liquid— Resolved
• Morphine PCA Syringes— Resolved
• Morphine Sulfate— No Longer Available
• Morphine Sulfate: Extended-Release Products
• Morphine Sulfate: Oral Concentrated Solution
• Oxycodone Combinations Capsules and Tablets
• Oxycodone Extended-Release Tablets— Resolved
• Oxycodone Tablets, Capsules, and Solutions
• Pentazocine / Naloxone Tablets
• Remifentanil Hydrochloride— Resolved
• Sufentanil Injection— Resolved

Updated

January 15, 2009, University of Utah, Drug Information Service.

Back to Drug Shortage Product Bulletins